Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$191.51 - $216.16 $2.22 Million - $2.5 Million
-11,566 Reduced 1.85%
612,737 $130 Million
Q2 2023

Aug 14, 2023

SELL
$187.64 - $206.25 $179 Million - $197 Million
-956,513 Reduced 60.51%
624,303 $120 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $87.5 Million - $139 Million
685,883 Added 76.64%
1,580,816 $320 Million
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $10.5 Million - $12.5 Million
89,624 Added 11.13%
894,933 $115 Million
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $231 Million - $308 Million
-1,709,580 Reduced 67.98%
805,309 $110 Million
Q2 2022

Aug 15, 2022

SELL
$108.81 - $179.33 $254 Million - $419 Million
-2,336,066 Reduced 48.16%
2,514,889 $445 Million
Q1 2022

May 16, 2022

SELL
$119.61 - $157.85 $213 Million - $282 Million
-1,784,291 Reduced 26.89%
4,850,955 $699 Million
Q4 2021

Feb 14, 2022

SELL
$142.57 - $190.86 $50.6 Million - $67.7 Million
-354,618 Reduced 5.07%
6,635,246 $1.03 Billion
Q3 2021

Nov 15, 2021

BUY
$142.45 - $169.82 $28.5 Million - $33.9 Million
199,759 Added 2.94%
6,989,864 $1.19 Billion
Q2 2021

Aug 16, 2021

SELL
$135.08 - $161.1 $43.8 Million - $52.2 Million
-324,065 Reduced 4.56%
6,790,105 $1.07 Billion
Q1 2021

May 17, 2021

SELL
$137.51 - $190.8 $56.7 Million - $78.6 Million
-412,070 Reduced 5.48%
7,114,170 $988 Million
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $1.24 Billion - $1.6 Billion
7,526,240 New
7,526,240 $1.32 Billion

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.